Digital Breast Tomosynthesis Market to Surge to $8.14B by 2032 | 14.2% CAGR

The global Digital Breast Tomosynthesis market is expected to grow at growth rate of 14.20% to reach USD 8,141.98 Million by 2032.

Digital breast tomosynthesis (DBT), commonly known as 3D mammography, is an advanced imaging technique designed to improve breast cancer detection, particularly in individuals with dense breast tissue. Unlike traditional 2D mammography, DBT captures multiple low-dose X-ray images from different angles while the breast remains compressed and positioned along an arc. These images are then digitally reconstructed into a detailed 3D representation, allowing radiologists to analyze breast tissue layer by layer. This enhanced visualization helps differentiate between malignant and healthy tissue with greater accuracy, reducing false positives and improving early cancer detection. By providing a clearer and more comprehensive view, DBT significantly enhances the effectiveness of breast cancer screenings.

Request Sample Copy of Report :Digital Breast Tomosynthesis Market

The growing global incidence of breast cancer is a major driver for the expansion of the digital breast tomosynthesis (DBT) market. In 2020, the World Health Organization reported that 2.3 million women were diagnosed with breast cancer, resulting in 685,000 deaths worldwide. By the end of that year, 7.8 million women had been diagnosed with breast cancer within the previous five years, making it the most prevalent cancer globally. This increasing number of diagnoses underscores the need for advanced diagnostic tools like DBT, which plays a vital role in enhancing breast cancer detection.

DBT improves detection rates by reconstructing breast tissue into three-dimensional images and presenting it in sequential layers, providing a clearer and more precise view of the breast. This technology significantly reduces false positives and recall rates, improving the accuracy of breast cancer screenings. Additionally, DBT is particularly effective in detecting ductal carcinoma in situ (DCIS), which refers to small, abnormal growths confined to the milk ducts that are usually non-harmful if caught early. The ability of DBT to facilitate early detection of such conditions is fueling its adoption and contributing to the market's growth.

KEY BENEFITS OF THE REPORT:

• Insights into strategies adopted by key players to maintain competitiveness.
• Comprehensive analysis of the leading companies shaping the competitive landscape.
• Examination of the key drivers fuelling global market growth.
• Identification of the geographic regions expected to experience the highest growth.
• Detailed evaluation of the current market conditions and future growth projections.

The digital breast tomosynthesis (DBT) market is highly competitive, with leading companies such as GE Healthcare, Analogic Corporation, Trivitron Healthcare, Siemens Healthineers, and Hologic Inc. actively implementing strategic initiatives to strengthen their market position. These industry leaders focus on continuous innovation, technological advancements, and product diversification to stay ahead in the evolving medical imaging landscape.

To meet growing demand for high-performance, efficient, and sustainable imaging solutions, companies are making substantial investments in research and development. A notable example is LG Electronics, which expanded its footprint in the B2B medical device sector in July 2024 with the launch of its FDA-approved 21HQ613D-B diagnostic monitor. This move underscores the company’s commitment to enhancing healthcare technology and improving diagnostic precision.

The scope of this report covers the market by its major segments, which include as follows:

Market Segmentation

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GE Healthcare

Analogic Corporation

Trivitron Healthcare

Siemens Healthineers

Hologic Inc.

General Electric Company

Internazionale Medico Scientifica

Canon Medical

FUJIFILM Holdings Corporation

PLANMED OY

Others

GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

Standalone 3D Systems

2D/3D Combination Systems

GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

Hospitals

Clinics

Diagnostics Centers

Others

GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America

o U.S.

o Canada

Europe

o Germany

o UK

o France

o Italy

o Spain

o The Netherlands

o Sweden

o Russia

o Poland

o Rest of Europe

Asia Pacific

o China

o India

o Japan

o South Korea

o Australia

o Indonesia

o Thailand

o Philippines

o Rest of APAC

Latin America

o Brazil

o Mexico

o Argentina

o Colombia

o Rest of LATAM

The Middle East and Africa

o Saudi Arabia

o UAE

o Israel

o Turkey

o Algeria

o Egypt

o Rest of MEA